Benefily
No prior authorization

Does Mcs Advantage, INC. require prior authorization for Quadracel?

Mcs Advantage, INC. does not require prior authorization for Quadracel on the Medicare Part D plans that cover it.

No covering plan from this payer files a prior-authorization requirement for this drug.

By product strength

RxNorm productPlans coveringRequire prior authStep therapyQty limitStatus
0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Quadracel]258705720 / 20000No prior authorization
0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Prefilled Syringe [Quadracel]259312120 / 20000No prior authorization

Product names come from RxNorm (U.S. National Library of Medicine).

Plan-by-plan detail — 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Quadracel]

Quadracel has 2 products in the corpus; this table is for 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.04 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.04 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / poliovirus vaccine inactivated, type 1 (Mahoney) 58 UNT/ML / poliovirus vaccine inactivated, type 2 (MEF-1) 14 UNT/ML / poliovirus vaccine inactivated, type 3 (Saukett) 52 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injection [Quadracel], the one carried on the most plans. The product table above covers every strength.

PlanContractTierPrior authStep therapyQty limit
MCS Classicare Efectivo (HMO)H5577-0051NoNoNo
MCS Classicare En Tu Hogar (HMO)H5577-0431NoNoNo
MCS Classicare Essential (HMO-POS)H5577-0081NoNoNo
MCS Classicare Estrella (HMO)H5577-0601NoNoNo
MCS Classicare Excede (HMO)H5577-0561NoNoNo
MCS Classicare Excede (HMO)H5577-0561NoNoNo
MCS Classicare Excede (HMO)H5577-0561NoNoNo
MCS Classicare Firme (HMO)H5577-0421NoNoNo
MCS Classicare Hero (HMO)H5577-0441NoNoNo
MCS Classicare InteliCare (HMO)H5577-0521NoNoNo
MCS Classicare Platino 185 (HMO D-SNP)H5577-0621NoNoNo
MCS Classicare Platino Ideal (HMO D-SNP)H5577-0021NoNoNo
MCS Classicare Platino Maximo (HMO D-SNP)H5577-0541NoNoNo
MCS Classicare Platino Maximo (HMO D-SNP)H5577-0541NoNoNo
MCS Classicare Platino Maximo (HMO D-SNP)H5577-0541NoNoNo
MCS Classicare Platino Progreso (HMO D-SNP)H5577-0171NoNoNo
MCS Classicare Platino Superior (HMO D-SNP)H5577-0611NoNoNo
MCS Classicare Platino Total (HMO D-SNP)H5577-0461NoNoNo
MCS Classicare Primero (HMO C-SNP)H5577-0381NoNoNo
MCS Classicare RxMax (HMO)H5577-0591NoNoNo
Source
Monthly Prescription Drug Plan Formulary and Pharmacy Network Information — Basic Drugs Formulary File
Effective
2026-06-30
Retrieved
2026-07-19
SHA-256
e626e6bcda1aa6a0071e6f0df6bafe686ae41842cdf0a9feffdc649b6d3ff3ae

We publish the hash of the exact file we ingested so any answer can be audited against the bytes CMS served that day.

Quadracel at other payers

Or see Quadracel across every payer at once.

Administrative information only. Benefily reports what a payer has published in its own prior-authorization policy as of the effective date shown. It is not medical advice, not a coverage or payment guarantee, and not an authorization. Requirements vary by plan, place of service and member benefits — always verify with the payer before rendering service.